May 4 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- BOARD UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT THE OFFER BY AUSTRALIAN CLINICAL LABS
- BOARD IS NOT OPPOSED TO ENGAGING IN DISCUSSIONS WITH ACL, OR ANOTHER PARTY, IN RELATION TO A CONTROL TRANSACTION OR MERGER PROPOSAL
- UNSOLICITED CONDITIONAL OFFER "OPPORTUNISTICALLY TIMED" AND WOULD RESULT IN AN "UNFAIR TRANSFER OF VALUE" FROM CO'S SHAREHOLDERS TO ACL
May 4 (Reuters) - Australian Clinical Labs Ltd (ACL) : BOARD...
Add to My Watchlist
What is My Watchlist?